Alzheimer's Disease Pathology in a Primate Model

灵长类动物模型中的阿尔茨海默病病理学

• 批准号: 10551282
• 负责人: WILLIAM D HOPKINS
• 金额: $ 74.62万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-02-15 至 2026-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10551282
• 关键词: Acceleration; Age; Aging; Alzheimer like pathology; Alzheimer' s Disease; Alzheimer' s disease model; Alzheimer' s disease pathology; Alzheimer' s disease patient; Alzheimer’s disease biomarker; Amyloid beta-42; Amyloid beta-Protein; Animal Model; Animals; Autopsy; Behavior; Behavioral; Biocompatible Materials; Biological; Biological Markers; Biology of Aging; Blood Vessels; Brain; Brain Diseases; Cell Death; Cells; Cerebral Amyloid Angiopathy; Cerebrovascular system; Characteristics; Chronology; Cognition; Cognitive; Cognitive deficits; Cohort Effect; Communities; Comparative Biology; Data; Dementia; Deposition; Deterioration; Disease; Elderly; Electron Microscopy; Epigenetic Process; Etiology; Exhibits; Future; Genetic; Genome; Goals; Health; Human; Impaired cognition; Individual; Inflammatory; Knowledge; LDL-Receptor Related Protein 1; Lesion; Lipoprotein Receptor; Longevity; Mammals; Measures; Mediating; Memory; Memory impairment; Methylation; Mitochondria; Modeling; Motor Skills; Nerve Degeneration; Neurofibrillary Tangles; Neurologic; Neurons; Neuropathy; Pan Genus; Pathologic; Pathology; Pattern; Performance; Pericytes; Phosphorylation; Play; Pongidae; Population; Prefrontal Cortex; Primates; Process; Proteins; Public Health; Regression Analysis; Research; Resources; Rodent; Sampling; Senile Plaques; Series; Site; Smooth Muscle Myocytes; Synapses; Testing; Therapeutic Intervention; Variant; abeta accumulation; abeta deposition; age difference; age related; aged; astrogliosis; behavior test; brain morphology; cognitive change; cognitive function; cognitive performance; cognitive testing; cohort; density; experience; glial activation; gray matter; human disease; individual variation; insight; mitochondrial dysfunction; neuroinflammation; neuron loss; neuropathology; neurovascular; nonhuman primate; species difference; tau Proteins; tissue biomarkers; translational study; translational therapeutics; walking speed; web portal; white matter

Project Summary Alzheimer's disease (AD) is a major health concern defined by pathologic changes in the brain that coincide with altered behavior and cognitive function. Animal models have advanced our understanding of AD, but these models artificially induce neuropathy to simulate the human disease. For instance, while amyloid- beta (Aβ) deposition occurs in most mammals, tau-positive neurofibrillary tangles (NFT) have only been identified in a few nonhuman species studied to date. Our research team recently discovered that chimpanzees, one of our closest genetic relatives, naturally develop both Aβ plaques and NFT, the pathological hallmarks of AD. In addition to AD pathology, elderly chimpanzees also develop cerebral amyloid angiopathy (CAA), a neurovascular condition found in 80% of AD patients associated with cognitive decline. Therefore, additional studies in chimpanzees could shed new light on the etiology of AD and CAA, leading to potentially new directions for therapeutic interventions. The overall goals of the proposed studies are to further examine the pathologic, epigenetic, and cognitive characteristics of aging, CAA, and AD in chimpanzees. In Aim 1, we will perform comprehensive pathologic analyses aimed at quantifying biomarkers of CAA and AD, including Aβ40 and Aβ42 plaque and vessel volumes, NFT density, pericyte and smooth muscle cell vessel volumes, neuron and synapse densities, and mitochondrial dysfunction. The collective neuropathologic measures will be examined in a sample of chimpanzees for which antemortem cognitive data is available, and the main focus will be determining which pathologic markers best predict individual variation in cognition. Moreover, we will test the correlation of AD and CAA pathologies with inflammatory processes, such as microglial activation and astrogliosis. In Aim 2, we will quantify epigenetic age in the chimpanzee population and evaluate whether chimpanzees with CAA or AD lesions demonstrate accelerated epigenetic aging in the brain relative to apes without pathology. We also will determine if epigenetic age is a better predictor than chronological age of changes in cognition, region-specific gray matter volume, and white matter integrity and connectivity. Finally, though previous studies have found cross-sectional age differences in cognition in chimpanzees, we will determine whether chimpanzees show longitudinal changes in cognition and whether any age-related loss in performance predicts the subsequent expression of AD pathology in this proposal. All biomaterials and cognitive data obtained in the proposed studies will be added to the National Chimpanzee Brain Resource and made publicly available to the scientific community through a web portal. The proposed studies, in their entirety, will fill an important gap in our knowledge about the comparative biology of aging and disease in chimpanzees and may provide critical translational insight into how those processes contribute to the progression of CAA and AD in humans. This information will provide crucial direction for future translational studies using rodent and nonhuman primate models.

项目摘要 阿尔茨海默病（AD）是一种主要的健康问题，其定义为大脑中的病理变化， 与行为和认知功能的改变相一致。动物模型促进了我们对AD的理解， 但是这些模型人工诱导神经病变以模拟人类疾病。例如，淀粉样蛋白- β（Aβ）沉积发生在大多数哺乳动物中，tau阳性神经元缠结（NFT）仅在 在迄今为止研究的一些非人类物种中发现。我们的研究小组最近发现黑猩猩， 我们最接近的遗传亲戚之一，自然发展Aβ斑块和NFT，这是 AD.除了AD病理学，老年黑猩猩还发生脑淀粉样血管病（CAA）， 在80%的AD患者中发现了与认知能力下降相关的神经血管疾病。因此提供附加 在黑猩猩中的研究可能为AD和CAA的病因学提供新的线索， 治疗干预的方向。拟议研究的总体目标是进一步审查 黑猩猩衰老、CAA和AD的病理学、表观遗传学和认知特征。在目标1中，我们 进行全面的病理分析，旨在量化CAA和AD的生物标志物，包括Aβ40 和Aβ42斑块和血管体积、NFT密度、周细胞和平滑肌细胞血管体积、神经元和 突触密度和线粒体功能障碍。将检查集体神经病理学指标 在一个黑猩猩样本中，可以获得死前认知数据，主要焦点将是 确定哪些病理标志物最能预测认知的个体差异。此外，我们将测试 AD和CAA病理与炎症过程的相关性，如小胶质细胞活化和 星形胶质细胞增生在目标2中，我们将量化黑猩猩群体的表观遗传年龄，并评估是否 与猿类相比，患有CAA或AD病变的黑猩猩的大脑表现出加速的表观遗传衰老 没有病理学。我们还将确定表观遗传年龄是否比实际年龄更能预测年龄。 认知、区域特异性灰质体积和白色物质完整性和连通性的变化。最后， 虽然先前的研究已经发现黑猩猩认知能力的横截面年龄差异，但我们将 确定黑猩猩是否表现出认知的纵向变化，以及是否有任何与年龄有关的损失， 在该建议中，性能预测AD病理学的后续表达。所有生物材料和 在拟议的研究中获得的认知数据将被添加到国家黑猩猩大脑资源中， 通过门户网站向科学界公布。拟议的研究，在其 整体而言，将填补我们对衰老和疾病的比较生物学知识的重要空白， 黑猩猩，并可能提供关键的翻译洞察这些过程如何有助于 人类CAA和AD的进展。这些信息将为未来的翻译提供重要的方向。 使用啮齿动物和非人类灵长类动物模型进行的研究。